Adherence of Cyanoacrylate which Leaked from Gastric Varices to the Left Renal Vein During Endoscopic Injection Sclerotherapy: A Histopathologic Study

Endoscopy ◽  
2000 ◽  
Vol 32 (10) ◽  
pp. 804-806 ◽  
Author(s):  
A. Irisawa ◽  
K. Obara ◽  
Y. Sato ◽  
A. Saito ◽  
H. Orikasa ◽  
...  
2008 ◽  
Vol 73 (2) ◽  
pp. 140-141
Author(s):  
Takao Miura ◽  
Ryu Nishiyama ◽  
Akifumi Ogihara ◽  
Shinya Masuoka ◽  
Akiko Hosoi ◽  
...  

2014 ◽  
Vol 146 (5) ◽  
pp. S-479
Author(s):  
Wataru Sato ◽  
Takashi Goto ◽  
Kentaro Kamada ◽  
Shigetoshi Ohshima ◽  
Kouichi Miura ◽  
...  

1996 ◽  
Vol 49 (0) ◽  
pp. 188-189
Author(s):  
Sayo Yamaoka ◽  
Shigehiro Kokubu ◽  
Yorio Matsumoto ◽  
Akira Asano ◽  
Katsunori Saigenji ◽  
...  

2004 ◽  
Vol 54 (2) ◽  
pp. 157-161
Author(s):  
Hirotaka Arai ◽  
Takumi Hoshino ◽  
Mitsuo Toyoda ◽  
Mamiko Nagashima ◽  
Atsushi Naganuma ◽  
...  

Endoscopy ◽  
2007 ◽  
Vol 39 (S 1) ◽  
pp. E242-E242 ◽  
Author(s):  
K. Akimoto ◽  
M. Inamori ◽  
T. Akiyama ◽  
H. Endo ◽  
K. Fujita ◽  
...  

2021 ◽  
pp. 28-34
Author(s):  
Keiji Yokoyama ◽  
Takashi Miyayama ◽  
Yotaro Uchida ◽  
Hiromi Fukuda ◽  
Ryo Yamauchi ◽  
...  

Gastric varices (GV) carry a high risk of massive hemorrhage because of potential rupture. To reduce the risk associated with GV, patients need to undergo hemostatic and preventive treatment. The objective of this retrospective study was to evaluate the usefulness of a new method, direct forward-viewing endoscopic ultrasonography (DFV-EUS) for the treatment of GV. We performed endoscopic injection sclerotherapy with histoacryl (EIS-HA) using DFV-EUS for GV in four patients. The paracentesis success rate was 75% (3/4). DFV-EUS has a significant advantage for the treatment of GV in that it can show physicians endoscopic and ultrasound views in real time during the delivery of the sclerosant into the GV. However, the proper use of the ultrasound view must be elucidated through further research for safer and more effective therapy. In the presence of distance between the mucosal surface and vascular lumen or when the blood flow site requires puncture as an additional treatment, DFV-EUS might be a good candidate for the treatment of GV. Altogether, EIS-HA with DFV-EUS might be a new therapeutic option for patients with GV.


Sign in / Sign up

Export Citation Format

Share Document